Category: Bio/Pharma/CRO
Unchained Labs locks down forever home with new Pleasanton campus
August 3, 2022 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics and gene therapy researchers the right tool for the job will build a new, expanded campus right around the corner from its current headquarters in Pleasanton, CA. Unchained entered into a very long-term (basically forever) lease on a... Read more
Thermo Fisher Scientific and Structura Biotechnology Collaborate to Offer a Solution for Real-Time Cryo-EM Data Analysis
New Embedded CryoSPARC Live software to be made available by Structura and Thermo Fisher and designed to integrate with Thermo Fisher technology HILLSBORO, Ore.–(BUSINESS WIRE)– Thermo Fisher Scientific Inc., the world leader in serving science, and Structura Biotechnology Inc., a leading provider of cryo-EM data analysis software, today announced a collaboration to make available a... Read more
PerkinElmer Streamlines Flow Cytometry Management For Biopharmaceutical Labs with New OneSource Concierge Service
WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has added PerkinElmer Flow Cytometry Instrument Concierge Services to its OneSource® Laboratory Services portfolio. The comprehensive and flexible offering will provide biopharmaceutical labs with expert, onsite flow cytometry specialists to help manage their instruments and processes more efficiently... Read more
Ellutia introduces fully automated total nitrosamine testing for pharmaceuticals at Analytica 2022
Ely, Cambridgeshire, 21st June, 2022: The Ellutia 800 Series Thermal EnergyAnalyser (TEA) has become the industry standard for nitrosamine detection thanks toits selectivity and sensitivity for nitroso compounds. For testing of pharmaceuticaldrugs, the 800 Series TEA can be interfaced to a chemical stripping system thatallows for rapid testing of apparent total nitrosamine content (ATNC). This... Read more
Bruker Acquires Optimal Companies for Pharma PAT Software and Biopharma Manufacturing Automation Expertise and Technologies
BILLERICA, Mass.–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Optimal Industrial Automation and Technologies, a leader in pharma and biopharma process analytical technology (PAT), pharma manufacturing automation and Quality Assurance (QA) software and systems integration, based in the United Kingdom. The Optimal biopharma tools acquisition strengthens Bruker as a key software and... Read more